/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Ovid Therapeutics

Ovid Therapeutics

United States

Ovid Therapeutics is developing a next generation of targeted small molecule therapies to reduce seizures and deliver improved safety and tolerability for neurological diseases and brain conditions.

Healthcare & Biotech

Ovid Therapeutics, based in United States, has 2 investors on file, among them Sanofi Ventures and TransPacific Venture Capital Partners. Its site was last checked 13 Nov 2026: site answers.

ovidrx.com

Investors

2 investors on file
InvestorEvidenceType
Sanofi VenturesPortfolio pageCorporate VC
TransPacific Venture Capital PartnersPortfolio pageVenture capital

In the news

6 headlines naming Ovid Therapeutics
Ono Pharmaceutical (OTCMKTS:OPHLF) vs. Ovid Therapeutics (NASDAQ:OVID) Head to Head Comparisondailypolitical.comOvid Therapeutics (NASDAQ:OVID) Shares Down 6.1% After Earnings Missthemarketsdaily.comOvid Therapeutics (NASDAQ:OVID) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPStickerreport.comOvid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Resultsmanilatimes.netOvid Therapeutics (NASDAQ:OVID) Issues Earnings Results, Misses Estimates By $0.02 EPSdailypolitical.comOvid Therapeutics Reports Q3 Results; Multiple Pipeline Readouts Expected In 2027rttnews.com

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from Sanofi Ventures

75 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

AbcuroAbcuro develops therapies for autoimmune diseases and cancer.AetionDatavant securely connects, protects, and activates health data across…Altesa BioSciencesAltesa BioSciences is developing a medicine to treat rhinovirus infect…Alveus TherapeuticsAlveus Therapeutics develops treatments for obesity and weight loss ma…Attovia TherapeuticsAttovia Therapeutics is developing next-generation biotherapeutics for…

See Sanofi Ventures' full profile · Who invests alongside it

More from TransPacific Venture Capital Partners

10 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

AnaptysBioAnaptysBio manages financial collaborations with pharmaceutical compan…G1 TherapeuticsG1 Therapeutics develops and delivers next generation therapies to imp…Zai LabZai Lab is a biopharmaceutical company that discovers, develops, and c…Beigene, LtdBeyondSpring PharmaceuticalsThe company develops and tests immune-modulating therapies for cancer …

See TransPacific Venture Capital Partners' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Ovid Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Sanofi Ventures adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/ovidrx.com/investors

# also
GET /v1/companies/ovidrx.com
GET /v1/companies/ovidrx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing